ArticleClinical and translational science2024

The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239.

Christine Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.